symbol,statement_type,period_end,line_item,value
PANACEABIO.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,107970000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.3
PANACEABIO.NS,income,2025-03-31 00:00:00,Normalized EBITDA,-52500000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Total Unusual Items,359900000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,359900000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-83700000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,348100000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,1995400000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,EBITDA,307400000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,EBIT,-40700000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Net Interest Income,-38800000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Interest Expense,38800000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Interest Income,
PANACEABIO.NS,income,2025-03-31 00:00:00,Normalized Income,-335630000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-83700000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Total Expenses,6198100000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
PANACEABIO.NS,income,2025-03-31 00:00:00,Diluted Average Shares,61094891.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Basic Average Shares,61094891.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Diluted EPS,-1.37
PANACEABIO.NS,income,2025-03-31 00:00:00,Basic EPS,-1.37
PANACEABIO.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,-83700000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,-83700000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Net Income,-83700000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Minority Interests,3500000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,-87200000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Net Income Discontinuous Operations,
PANACEABIO.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,-87200000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Tax Provision,7700000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Pretax Income,-79500000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,206600000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Special Income Charges,359900000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Other Special Charges,-359900000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Write Off,
PANACEABIO.NS,income,2025-03-31 00:00:00,Impairment Of Capital Assets,
PANACEABIO.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-38800000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
PANACEABIO.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,38800000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
PANACEABIO.NS,income,2025-03-31 00:00:00,Operating Income,-607200000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Operating Expense,4202700000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Other Operating Expenses,2124100000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,348100000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Amortization,
PANACEABIO.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,348100000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Selling General And Administration,
PANACEABIO.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
PANACEABIO.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
PANACEABIO.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
PANACEABIO.NS,income,2025-03-31 00:00:00,Gross Profit,3595500000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Cost Of Revenue,1995400000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Total Revenue,5590900000.0
PANACEABIO.NS,income,2025-03-31 00:00:00,Operating Revenue,5590900000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,108090000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.3
PANACEABIO.NS,income,2024-03-31 00:00:00,Normalized EBITDA,57400000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Total Unusual Items,360300000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,360300000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-11700000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,367100000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,2301200000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,EBITDA,417700000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,EBIT,50600000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Net Interest Income,-35800000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Interest Expense,35800000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Interest Income,83730000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Normalized Income,-263910000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-11700000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Total Expenses,6159400000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,33960000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Diluted Average Shares,61578947.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Basic Average Shares,61578947.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Diluted EPS,-0.19
PANACEABIO.NS,income,2024-03-31 00:00:00,Basic EPS,-0.19
PANACEABIO.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,-11700000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,-11700000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Net Income,-11700000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Minority Interests,3300000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,-15000000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Net Income Discontinuous Operations,
PANACEABIO.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,-15000000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Tax Provision,29800000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Pretax Income,14800000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,258000000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Special Income Charges,360300000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Other Special Charges,-360300000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Write Off,5430000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Impairment Of Capital Assets,46140000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-35800000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,9080000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,35800000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,83730000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Operating Income,-567700000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Operating Expense,3858200000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Other Operating Expenses,1995400000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,367100000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Amortization,23510000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,367100000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Selling General And Administration,580500000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,285240000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,General And Administrative Expense,295260000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,33960000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Gross Profit,3290500000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Cost Of Revenue,2301200000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Total Revenue,5591700000.0
PANACEABIO.NS,income,2024-03-31 00:00:00,Operating Revenue,5591700000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,316242000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.3
PANACEABIO.NS,income,2023-03-31 00:00:00,Normalized EBITDA,-496830000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Total Unusual Items,1054140000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,1054140000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-332370000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,391230000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,2787580000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,EBITDA,557310000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,EBIT,166080000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Net Interest Income,71240000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Interest Expense,38030000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Interest Income,115610000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Normalized Income,-1070268000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-332370000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Total Expenses,5625730000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,34420000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Diluted Average Shares,61250746.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Basic Average Shares,61250746.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Diluted EPS,-5.43
PANACEABIO.NS,income,2023-03-31 00:00:00,Basic EPS,-5.43
PANACEABIO.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,-332370000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,-332370000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Net Income,-332370000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Minority Interests,5080000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,-337450000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Net Income Discontinuous Operations,
PANACEABIO.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,-337450000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Tax Provision,465500000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Pretax Income,128050000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,33430000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Special Income Charges,1039670000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Other Special Charges,-1073890000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Write Off,4280000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Impairment Of Capital Assets,29940000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,71240000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,6340000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,38030000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,115610000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Operating Income,-1056540000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Operating Expense,2838150000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Other Operating Expenses,584280000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,391230000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Amortization,2750000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,388480000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Selling General And Administration,585450000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,427050000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,General And Administrative Expense,158400000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,34420000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Gross Profit,1781610000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Cost Of Revenue,2787580000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Total Revenue,4569190000.0
PANACEABIO.NS,income,2023-03-31 00:00:00,Operating Revenue,4569190000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,4286924061.845399
PANACEABIO.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.255991
PANACEABIO.NS,income,2022-03-31 00:00:00,Normalized EBITDA,-16690000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Total Unusual Items,16746390000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,16746390000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,10783150000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,437770000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,3176680000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,EBITDA,16729700000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,EBIT,16291930000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Net Interest Income,-1774450000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Interest Expense,1798370000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Interest Income,33940000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Normalized Income,-1676315938.154601
PANACEABIO.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,10783150000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Total Expenses,7110380000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,33970000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Diluted Average Shares,61250746.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Basic Average Shares,61250746.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Diluted EPS,176.05
PANACEABIO.NS,income,2022-03-31 00:00:00,Basic EPS,176.05
PANACEABIO.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,10783150000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,10783150000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Net Income,10783150000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Minority Interests,-190000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,10783340000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Net Income Discontinuous Operations,0.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,10783340000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Tax Provision,3710220000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Pretax Income,14493560000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,33970000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Special Income Charges,16746380000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Other Special Charges,-16762130000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Write Off,0.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Impairment Of Capital Assets,15750000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-1774450000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,10020000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,1798370000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,33940000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Operating Income,-518150000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Operating Expense,3933700000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Other Operating Expenses,879790000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,437770000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Amortization,7600000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,430170000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Selling General And Administration,757550000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,480840000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,General And Administrative Expense,276710000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,33970000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Gross Profit,3415550000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Cost Of Revenue,3176680000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Total Revenue,6592230000.0
PANACEABIO.NS,income,2022-03-31 00:00:00,Operating Revenue,6592230000.0
PANACEABIO.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
PANACEABIO.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
PANACEABIO.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
PANACEABIO.NS,income,2021-03-31 00:00:00,Total Unusual Items,
PANACEABIO.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
PANACEABIO.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
PANACEABIO.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
PANACEABIO.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
PANACEABIO.NS,income,2021-03-31 00:00:00,EBITDA,
PANACEABIO.NS,income,2021-03-31 00:00:00,EBIT,
PANACEABIO.NS,income,2021-03-31 00:00:00,Net Interest Income,
PANACEABIO.NS,income,2021-03-31 00:00:00,Interest Expense,
PANACEABIO.NS,income,2021-03-31 00:00:00,Interest Income,32680000.0
PANACEABIO.NS,income,2021-03-31 00:00:00,Normalized Income,
PANACEABIO.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
PANACEABIO.NS,income,2021-03-31 00:00:00,Total Expenses,
PANACEABIO.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,28670000.0
PANACEABIO.NS,income,2021-03-31 00:00:00,Diluted Average Shares,
PANACEABIO.NS,income,2021-03-31 00:00:00,Basic Average Shares,
PANACEABIO.NS,income,2021-03-31 00:00:00,Diluted EPS,
PANACEABIO.NS,income,2021-03-31 00:00:00,Basic EPS,
PANACEABIO.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
PANACEABIO.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
PANACEABIO.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
PANACEABIO.NS,income,2021-03-31 00:00:00,Net Income,
PANACEABIO.NS,income,2021-03-31 00:00:00,Minority Interests,
PANACEABIO.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
PANACEABIO.NS,income,2021-03-31 00:00:00,Net Income Discontinuous Operations,-14550000.0
PANACEABIO.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
PANACEABIO.NS,income,2021-03-31 00:00:00,Tax Provision,
PANACEABIO.NS,income,2021-03-31 00:00:00,Pretax Income,
PANACEABIO.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
PANACEABIO.NS,income,2021-03-31 00:00:00,Special Income Charges,
PANACEABIO.NS,income,2021-03-31 00:00:00,Other Special Charges,
PANACEABIO.NS,income,2021-03-31 00:00:00,Write Off,0.0
PANACEABIO.NS,income,2021-03-31 00:00:00,Impairment Of Capital Assets,2660000.0
PANACEABIO.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
PANACEABIO.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,6450000.0
PANACEABIO.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
PANACEABIO.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,32680000.0
PANACEABIO.NS,income,2021-03-31 00:00:00,Operating Income,
PANACEABIO.NS,income,2021-03-31 00:00:00,Operating Expense,
PANACEABIO.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
PANACEABIO.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
PANACEABIO.NS,income,2021-03-31 00:00:00,Amortization,8280000.0
PANACEABIO.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
PANACEABIO.NS,income,2021-03-31 00:00:00,Selling General And Administration,786480000.0
PANACEABIO.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,511810000.0
PANACEABIO.NS,income,2021-03-31 00:00:00,General And Administrative Expense,274670000.0
PANACEABIO.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,28670000.0
PANACEABIO.NS,income,2021-03-31 00:00:00,Gross Profit,
PANACEABIO.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
PANACEABIO.NS,income,2021-03-31 00:00:00,Total Revenue,
PANACEABIO.NS,income,2021-03-31 00:00:00,Operating Revenue,
